Aegros is an Australian pharmaceutical company dedicated to improving patient lives through the development of therapeutic plasma products. Founded on the belief that access to life-saving plasma-derived medications should be a human right, Aegros has developed innovative processes such as HaemaFrac™ to transform collected human plasma into critical hyperimmune therapies. The company emphasizes a patient-first approach, aiming to address unmet medical needs with safe and effective solutions. As Aegros experiences rapid growth, it fosters a collaborative and multicultural work environment, where employees are encouraged to contribute to continuous improvement and innovation while making a tangible impact on healthcare outcomes.